Plans to launch a treatment option for Urea Cycle Disorders (UCDs) with comprehensive patient support* are underway!
Cycle Pharmaceuticals is getting ready to support patients with UCDs in the US.
We have been supporting patients with rare metabolic diseases since 2017, so we understand the importance of providing individualized support that complements their treatment.
Our Clinical Education Managers within Cycle Vita™ are used to working with patients with rare metabolic disorders. They are registered dietitians with years of experience. They are looking forward to extending their support to patients with UCDs.
Stay up to date!
Sign up to receive emails with product information, what to expect, and launch updates.
Hear from our patient support team at Cycle Vita on how they can support you.
*Some areas of support may not be accessible to all patients. Eligibility criteria may apply to ensure compliance with all applicable federal and state requirements, and benefits may be limited to commercially insured patients only. For more detailed information about eligibility, terms and conditions, please contact the Cycle Vita team at 888-360-8482.
At the time of writing, Taia was taking a Cycle Pharmaceuticals treatment and was compensated for her time.
Cycle Vita™ is a trademark of Cycle Pharmaceuticals Limited in the United States.